Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Dermisonics Inc

Healthcare US DMSI

0.0USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

52 Week Range

--
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00192M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.44

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Type yearly yearly yearly yearly
Date 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Income before tax -5.08405M -6.95869M -3.95864M -0.05539M
Minority interest - - - -
Net income -5.08405M -6.95869M -3.99315M -0.08250M
Selling general administrative 4.11M 5.73M 3.74M 0.06M
Selling and marketing expenses - - - -
Gross profit 0.00000M 0.00000M 0.00000M 0.00000M
Reconciled depreciation - - - -
Ebit -4.11201M -5.72911M -3.84436M -0.05539M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -4.11201M -5.72911M -3.84436M -0.05539M
Other operating expenses - - - -
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - 0.37M 0.37M -
Other items - - - -
Income tax expense 0.00000M 0.00000M 0.00000M 0.00000M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 4.11M 5.73M 3.84M 0.06M
Cost of revenue 0.00000M 0.00000M 0.00000M 0.00000M
Total other income expense net -0.97203M -1.22958M -0.11429M 0.00000M
Discontinued operations - - -0.03451M -0.02711M
Net income from continuing ops -5.08405M -6.95869M -3.95864M -0.05539M
Net income applicable to common shares -5.08405M -6.95869M -3.99315M -0.08250M
Preferred stock and other adjustments - - - -
Breakdown 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Type yearly yearly yearly yearly
Date 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Total assets 20.08M 19.91M 19.45M 0.04M
Intangible assets 19.46M 19.46M 19.45M 0.02M
Earning assets - - - -
Other current assets 0.41M 0.00507M - -
Total liab 4.47M 4.15M 3.33M 0.00864M
Total stockholder equity 15.62M 15.76M 16.12M 0.03M
Deferred long term liab 0.09M 0.09M - -
Other current liab - - 0.38M -
Common stock 0.05M 0.04M 0.12M 0.06M
Capital stock - - - -
Retained earnings -16.48861M -11.40456M -4.44587M -0.45273M
Other liab 0.06M 0.03M - -
Good will - - - 0.00951M
Other assets 0.09M 0.09M - -
Cash 0.13M 0.36M - 0.00340M
Cash and equivalents - - - -
Total current liabilities 3.90M 1.95M 2.08M 0.00864M
Current deferred revenue - - - -
Net debt - - - -
Short term debt 2.56M 1.25M 0.65M -
Short long term debt 2.56M 1.25M 0.65M -
Short long term debt total - - - -
Other stockholder equity 0.00075M 0.00011M 0.00839M -
Property plant equipment 0.00302M - - 0.00040M
Total current assets 0.53M 0.36M - 0.00340M
Long term investments - - - -
Net tangible assets -3.84199M -3.69559M -3.33316M -0.00484M
Short term investments - - - -
Net receivables - - - -
Long term debt 0.51M 2.17M 1.26M -
Inventory - - - -
Accounts payable 0.38M 0.27M 0.46M 0.00864M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total - - - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Type yearly yearly yearly yearly
Date 2006-09-30 2005-09-30 2004-09-30 2003-09-30
Investments - - - -
Change to liabilities 0.69M -0.11830M 0.46M -0.00736M
Total cashflows from investing activities -0.00302M -0.01006M -0.50000M -0.50000M
Net borrowings -0.11411M 1.42M 0.56M 0.56M
Total cash from financing activities 1.08M 1.59M 0.56M 0.56M
Change to operating activities -0.16307M 0.04M 0.41M 0.41M
Net income -5.08405M -6.95869M -3.99315M -0.08250M
Change in cash -0.23092M 0.36M -0.00340M -0.07466M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities -1.30486M -1.22336M -0.06290M -0.07466M
Issuance of capital stock - - - -
Depreciation 0.22M 0.00409M 0.01M 0.02M
Other cashflows from investing activities - -0.01006M -0.50000M -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables - - - -
Sale purchase of stock 0.49M 0.26M 0.26M 0.26M
Other cashflows from financing activities 0.70M -0.09208M -0.09208M -0.09208M
Change to netincome 3.03M 5.41M 3.06M 3.06M
Capital expenditures 0.00302M 0.00302M 0.00302M 0.00302M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
DMSI
Dermisonics Inc		 - -% - - - - -
ABT
Abbott Laboratories		 -0.58 0.66% 87.83 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 -3.11 1.01% 304.69 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.07 0.09% 79.27 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.96 2.12% 44.33 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.

Dermisonics Inc

2 Park Plaza, Irvine, CA, United States, 92614

  • 949-733-1101

Key Executives

Name Title Year Born
Mr. Bruce H. Haglund Exec. Chairman, Acting Principal Exec.,Financial & Accounting Officer 1952
Mr. Bruce H. Haglund Esq., J.D. Executive Chairman, Acting Principal Exec.,Financial & Accounting Officer 1952

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions